Axsome Therapeutics (AXSM) Total Debt Growth (1y) (2017 - 2026)
Axsome Therapeutics (AXSM) Total Debt Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 103.99% |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 3.84% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 0.07% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Axsome Therapeutics | 12.28 Bn | 11.98 Bn | 176.48 Mn | -32.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.10% |
| Dec 31, 2025 | -29.30% |
| Sep 30, 2025 | 44.49% |
| Jun 30, 2025 | -31.98% |
| Mar 31, 2025 | 2.65% |
| Dec 31, 2024 | -2.04% |
| Sep 30, 2024 | -52.13% |
| Jun 30, 2024 | 1.75% |
| Mar 31, 2024 | 20.48% |
| Dec 31, 2023 | 84.18% |
| Sep 30, 2023 | 82.45% |
| Jun 30, 2023 | 84.25% |
| Mar 31, 2023 | 211.51% |
| Dec 31, 2022 | 104.03% |
| Sep 30, 2022 | 105.22% |
| Jun 30, 2022 | 103.36% |
| Mar 31, 2022 | 1.47% |
| Dec 31, 2021 | 1.59% |
| Sep 30, 2021 | -10.59% |
| Jun 30, 2021 | 140.90% |